药代动力学与实验治疗学杂志

抽象的

A Study of CYP2C19 Activity in Populations of European and Japanese Ancestry Using a Physiologically 10.4172/jpet.1000145Based Pharmacokinetic Model of Clopidogrel

Naveen Pereira

Clopidogrel treatment response is linked to CYP2C19 activity, which is measured by the active H4 metabolite. The researchers wanted to create a physiologically based pharmacokinetic (PBPK) model of clopidogrel and its metabolites for European ancestry populations, predict pharmacokinetics in the Japanese population using the CYP2C19 phenotype, and look into the impact of clinical and demographic parameters. Using plasma data from previous research, a PBPK model was created and proven to describe the two metabolic routes of clopidogrel (H4 metabolite, acyl glucuronide metabolite) for a population of European ancestry